Follow the people · Insider
Peter B. Cancelmo
Peter B. Cancelmo files insider transactions with the SEC as a vp, general counsel of Omeros (OMER). We hold 2 disclosed purchases and sales filed since 11 June 2019, 2 of them in the last 90 days.
- Files forOMER
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure1 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 June 2019 — 31 August 2026VP, General Counsel · Omeros (OMER)15 Form 4 lines · source: SEC Form 4
Everything they disclosed
15 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 25,000 shares of OmerosSEC Form 41 September 2026Common Stock · traded 28 August 2026 · filed 1 September 2026
- ▼ sold on the open market 25,000 shares of OmerosSEC Form 41 September 2026Common Stock · traded 28 August 2026 · filed 1 September 2026
- exercised options over 25,000 shares of OmerosSEC Form 41 September 2026Common Stock · traded 31 August 2026 · filed 1 September 2026
- ▼ sold on the open market 25,000 shares of OmerosSEC Form 41 September 2026Common Stock · traded 31 August 2026 · filed 1 September 2026
- exercised options over 25,000 shares of Omeros (a derivative holding)SEC Form 41 September 2026Stock Option (Right to Buy) · traded 28 August 2026 · filed 1 September 2026
- exercised options over 25,000 shares of Omeros (a derivative holding)SEC Form 41 September 2026Stock Option (Right to Buy) · traded 31 August 2026 · filed 1 September 2026
- was granted 105,000 shares of Omeros (a derivative holding)SEC Form 424 July 2026Stock Option (right to buy) · traded 22 July 2026 · filed 24 July 2026
- was granted 100,000 shares of Omeros (a derivative holding)SEC Form 41 July 2025Stock Option (right to buy) · traded 30 June 2025 · filed 1 July 2025
- was granted 100,000 shares of Omeros (a derivative holding)SEC Form 429 April 2024Stock Option (right to buy) · traded 25 April 2024 · filed 29 April 2024
- was granted 100,000 shares of Omeros (a derivative holding)SEC Form 427 September 2023Stock Option (right to buy) · traded 22 September 2023 · filed 27 September 2023
- was granted 80,000 shares of Omeros (a derivative holding)SEC Form 423 September 2022Stock Option (right to buy) · traded 21 September 2022 · filed 23 September 2022
- was granted 75,000 shares of Omeros (a derivative holding)SEC Form 46 July 2021Stock Option (right to buy) · traded 2 July 2021 · filed 6 July 2021
- was granted 20,000 shares of Omeros (a derivative holding)SEC Form 428 October 2020Stock Option (right to buy) · traded 26 October 2020 · filed 28 October 2020
- was granted 50,000 shares of Omeros (a derivative holding)SEC Form 43 March 2020Stock Option (right to buy) · traded 1 March 2020 · filed 3 March 2020
- was granted 20,000 shares of Omeros (a derivative holding)SEC Form 411 June 2019Stock Option(Right to Buy) · traded 10 June 2019 · filed 11 June 2019
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.